Mark S. Blumenkranz, CEO & Chairman
By

“I’ve had the fortunate opportunity  to work closely with Mark Murray of FLG Partners in a series of  four  successful venture backed -backed companies in Silicon Valley  over the past dozen years including Optimedica Corporation (acquired by Abbott), Oculeve (acquired by Allergan), Oyster Point Pharmaceuticals (IPO) and most recently Kedalion Therapeutics (acquired by Novartis)….Read More

Read More
Springboard
By
Read More
Golden Gate National Parks Conservancy
By
Read More
ALX Oncology
By
Read More